Methane

Methane

SCHEMBL27699324

C.CCCCC=C[O]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28769 0.97
SCHEMBL28768 0.97
SCHEMBL7286617 0.92 FAAH (0.48)
SCHEMBL7287333 0.92 TRPV1 (0.48)
SCHEMBL7286614 0.92 FAAH (0.48)
SCHEMBL7348367 0.92 TRPV1 (0.48)
SCHEMBL28822 0.88
SCHEMBL28821 0.88
SCHEMBL129255 0.86 FAAH (0.61)
SCHEMBL131304 0.86 FAAH (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103990111-A Methods for attenuating release of inflammatory mediators and peptides useful therein BIOMARCK PHARMACEUTICALS LTD 2014-08-20 CN disclosed
CN-101516190-B Methods for reducing inflammatory mediator release and peptides useful therefor BIOMARCK PHARMACEUTICALS LTD 2014-06-11 CN disclosed
CN-101146545-B Mucin hypersecretion inhibitors based on the structure of MANS and methods of use BIOMARCK PHARMACEUTICALS LTD 2012-12-26 CN disclosed
CN-101516190-A Methods for reducing inflammatory mediator release and peptides useful therefor BIOMARCK PHARMACEUTICALS LTD (US) 2009-08-26 CN disclosed
CN-101146545-A Mucin hypersecretion inhibitors based on the structure of MANS and methods of use BIOMARCK PHARMACEUTICALS LTD (US) 2008-03-19 CN disclosed